Form 8-K Valeant Pharmaceuticals For: Apr 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Valeant Pharma (VRX) Details Compensation for Incoming CEO Papa, Outgoing CEO Pearson
April 28, 2016 6:21 AM EDTValeant Pharma (NYSE: VRX) disclosed teh following late Thursday:
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Joseph C. Papa -- New Chairman and CEO
On April 25, 2016, the Board of Directors (the Board) of Valeant Pharmaceuticals International, Inc. (Valeant or the Company) announced the appointment of Joseph C. Papa to become Valeants Chairman and Chief Executive Officer. Mr. Papa, is expected to join the Company by early May and will succeed J.... More
